The practical management of fluid retention in adults with right heart failure due to pulmonary arterial hypertension

The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology

(2019) Wilfried Mullens et al.   EUROPEAN JOURNAL OF HEART FAILURE

Pulmonary Arterial Hypertension: Combination Therapy in Practice

(2018) Marsha Burks et al.   American Journal of Cardiovascular Drugs

Outcomes of patients with systolic heart failure presenting with sepsis to the emergency department of a tertiary hospital: a retrospective chart review study from Lebanon

(2018) Gilbert Abou Dagher et al.   BMJ Open

ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension

(2018) Ekkehard Grünig et al.   EUROPEAN RESPIRATORY JOURNAL

Endothelin ET A Receptor Blockade, by Activating ET B Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention

(2017) Magali Vercauteren et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Diuretics for Hypertension: A Review and Update

(2016) George C. Roush et al.   AMERICAN JOURNAL OF HYPERTENSION

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology

(2016) Veli-Pekka Harjola et al.   EUROPEAN JOURNAL OF HEART FAILURE

Chronic Kidney Disease, Fluid Overload and Diuretics: A Complicated Triangle

(2016) Yusra Habib Khan et al.   PLoS One

Clinical Adverse Effects of Endothelin Receptor Antagonists: Insights From the Meta‐Analysis of 4894 Patients From 24 Randomized Double‐Blind Placebo‐Controlled Clinical Trials

(2016) Anhua Wei et al.   Journal of the American Heart Association

Palliative care in pulmonary arterial hypertension

(2016) Wendy Gin-Sing   Current Opinion in Supportive and Palliative Care

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

(2015) Nazzareno Galiè et al.   NEW ENGLAND JOURNAL OF MEDICINE

Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

(2015) A Dasgupta et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The jugular venous pressure revisited

(2013) J. M. S. CHUA CHIACO et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Abdominal Contributions to Cardiorenal Dysfunction in Congestive Heart Failure

(2013) Frederik H. Verbrugge et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Frequency of Edema in Patients With Pulmonary Arterial Hypertension Receiving Ambrisentan

(2012) Shelley Shapiro et al.   AMERICAN JOURNAL OF CARDIOLOGY

Tratamiento basado en la evidencia de la insuficiencia cardiaca derecha: una revisión sistemática de un campo empírico

(2011) Mehdi Skhiri et al.   REVISTA ESPANOLA DE CARDIOLOGIA

C-Reactive Protein

(2009) Rozenn Quarck et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

(2009) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary Hypertension: Diagnosis and Management

(2009) Michael D. McGoon et al.   MAYO CLINIC PROCEEDINGS

Pulmonary Hypertension, Right Ventricular Failure, and Kidney: Different from Left Ventricular Failure?

(2008) R. W. Schrier et al.   Clinical Journal of the American Society of Nephrology